Covid reinfections: Are they milder and do they strengthen immunity?

Covid, New Strain, Virus, WHO , Disorder, Pharmanews , Biopharmaceutical, Company

We’ve known since early on in the pandemic that Covid reinfections could occur. One of the first reinfections reported was in a 33-year-old man from Hong Kong. His initial infection was diagnosed on March 26 2020, with his second infection, with a genetically distinct virus, being diagnosed 142 days later.

Since then reports of reinfection have become common, especially since the emergence of the omicron variant. Early research from South Africa (still in preprint, so awaiting review by other scientists) suggests that the risk of reinfection increased quickly and substantially after the variant arrived.

The simple answer is because our immunity is often no longer sufficient to prevent an infection. This can be due to the appearance of a new viral variant like omicron that, because of mutations to its form, is less recognisable to the immune system, meaning the virus bypasses prior immunity. Or it can be because immunity has waned since we were last infected or vaccinated. We know that this is a particular issue with Covid immunity – hence the need for vaccine boosters.

The coronavirus almost always enters the human body via the nose and throat. Immunity in the mucosal linings of these areas tends to be relatively short-lived compared to systemic immunity throughout the body. This may explain why protection against severe illness, usually rooted in the lungs, lasts longer than protection against infection.

How common are reinfections?

The UK has recently started publishing data on reinfections on its Covid dashboard. It classifies a reinfection as someone receiving a new positive Covid test result more than 90 days after their last infection.

Up to February 6, 2022, there had been over 14.5 million primary infections and around 620,000 reinfections in England – so one reinfection for every 24 primary infections. Over 50 per cent of all reinfections have been reported since December 1, 2021, suggesting again that the risk of reinfection has increased substantially with omicron.

The UK’s Office for National Statistics (ONS) also measures reinfections, although does so differently. For someone to count as being reinfected, there needs to be 120 days or four consecutive negative PCR tests between the positive tests confirming their two cases. The ONS suggests that the rate of reinfection has increased 15-fold since the arrival of omicron, and that currently reinfections account for about 10% of all infections reported in England, compared to just 1% during November 2021.

However, these figures could be a significant underestimate. The 90- or 120-day gap will undoubtedly miss some reinfections that occur sooner. Plus, by comparing daily recorded case numbers with estimates of how much of the population is infected with the virus at any given point in time, it appears around half of primary infections are never diagnosed. Many reinfections are therefore likely to be incorrectly categorised as primary ones. Also, if reinfections are generally milder, a higher proportion are likely to be undiagnosed.

But are reinfections milder?

Primary infections in vaccinated people (who have some COVID immunity) are generally less severe than primary infections in unvaccinated people (who don’t have any immunity) – this is why hospitalisation rates are lower among the vaccinated.

It’s reasonable therefore to assume that, in general, reinfections should be less severe than primary infections, as the person being reinfected will have some pre-existing immunity from their primary infection. Plus, many people will have been vaccinated between their infections, which will have further raised their levels of immunity.

Even though immunity against being infected by the coronavirus and developing Covid symptoms wanes, protection against severe disease and death appears much more durable. So at the extreme end of things, reinfections definitely seem to be less severe.

But, whether your second infection ends up not feeling as bad as your first may depend on when you get infected. ONS data shows the proportion of people reporting symptoms with their reinfection varies depending on what variant they were likely infected with second time round.

The ONS estimates that reinfections with alpha gave people symptoms only 20 per cent of the time, whereas delta reinfections caused symptoms in 44 per cent of cases and omicron in 46 per cent. Its data also shows that people reinfected with alpha were much less likely to get symptoms the second time compared to their primary infection. Whereas delta reinfections were somewhat more likely to give people symptoms compared to their primary infection. With an omicron reinfection, the rate of symptoms was about the same across the reinfection and primary infection.

We know that the severity of Covid varies from one variant to another. However, it’s difficult to distinguish how much of the difference above is down to the different strengths of the variants, and how much is due to levels of Covid immunity from prior infection and vaccination present in people at the time.

A question that remains unanswered is whether an omicron infection in an unvaccinated person is less severe if that person has already been infected. In a small omicron outbreak in a US household, one unvaccinated person caught the virus for the first time and four unvaccinated others for the second. The illness of the person experiencing the virus for the first time was more severe the illness of those reinfected – but the very small number of cases precludes any firm conclusions.

On the other hand, there have been opposing reports in the past of more severe disease being caused by reinfection. So while it’s plausible that reinfections should be milder, at the moment, we’re still lacking robust evidence that proves this.

Do reinfections strengthen immunity?

Almost certainly yes. A single, prior infection gives similar protection against infection with omicron as two doses of vaccine, so it’s reasonable to assume that reinfections will also boost immunity.

But such immunity still won’t be 100 per cent protective. There’s emerging evidence (in preprint) of people being reinfected multiple times. This, though, shouldn’t be surprising, as we know the other human coronaviruses cause reinfections every few years

For more Information: Sign in Websites for Agrochemical & Pharmaceutical Databases:

Website : https://www.chemrobotics.com/ (Agrochemical Databases)

Website : https://chemroboticspharma.com/  (Pharmaceutical Databases)

Related posts

GSK and Wave Life Sciences Establish a Partnership to further the Identification and Development of Therapeutic Oligonucleotides that Target Novel Genomic Targets.

National CDC-Funded Study Confirms that mRNA Vaccines Protect Against Serious COVID-19 During Pregnancy

Pfizer and BioNTech are being Sued by Moderna for Patent Infringement over Covid Drug mRNA Technology Platform.